These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3438 related items for PubMed ID: 18498797

  • 21. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC, Untch B, Aranha GV, Mohideen N, Hantel A, Pickleman J.
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [Abstract] [Full Text] [Related]

  • 22. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
    Sujendran V, Wheeler J, Baron R, Warren BF, Maynard N.
    Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
    [Abstract] [Full Text] [Related]

  • 23. Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II study.
    Orditura M, Galizia G, Napolitano V, Martinelli E, Pacelli R, Lieto E, Aurilio G, Vecchione L, Morgillo F, Catalano G, Ciardiello F, Del Genio A, Di Martino N, De Vita F.
    Cancer Invest; 2010 Oct; 28(8):820-7. PubMed ID: 20482249
    [Abstract] [Full Text] [Related]

  • 24. Management for patients with advanced T4 epidermoid carcinoma of the esophagus.
    Wang LS, Chi KH, Hu MH, Fahn HJ, Huang MH.
    J Surg Oncol; 1996 May; 62(1):22-9. PubMed ID: 8618396
    [Abstract] [Full Text] [Related]

  • 25. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
    Hsu FM, Lin CC, Lee JM, Chang YL, Hsu CH, Tsai YC, Lee YC, Cheng JC.
    J Surg Oncol; 2008 Jul 01; 98(1):34-41. PubMed ID: 18449912
    [Abstract] [Full Text] [Related]

  • 26. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.
    Korst RJ, Kansler AL, Port JL, Lee PC, Kerem Y, Altorki NK.
    Ann Thorac Surg; 2006 Aug 01; 82(2):480-4; discussion 484-5. PubMed ID: 16863749
    [Abstract] [Full Text] [Related]

  • 27. Neoadjuvant, surgery and adjuvant chemotherapy without radiation for esophageal cancer.
    Ardalan B, Spector SA, Livingstone AS, Franceschi D, Mezentsev D, Lima M, Bowen-Wells CP, Sparling L, Avisar E, Sapp M, Rios J, Walker G, Ganjei-Azar P.
    Jpn J Clin Oncol; 2007 Aug 01; 37(8):590-6. PubMed ID: 17704532
    [Abstract] [Full Text] [Related]

  • 28. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
    Abbrederis K, Bassermann F, Schuhmacher C, Voelter V, Busch R, Roethling N, Sendler A, Siewert JR, Peschel C, Lordick F.
    Ann Thorac Surg; 2006 Jul 01; 82(1):293-7. PubMed ID: 16798232
    [Abstract] [Full Text] [Related]

  • 29. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
    Spigel DR, Greco FA, Meluch AA, Lane CM, Farley C, Gray JR, Clark BL, Burris HA, Hainsworth JD.
    J Clin Oncol; 2010 May 01; 28(13):2213-9. PubMed ID: 20351330
    [Abstract] [Full Text] [Related]

  • 30. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus.
    Heath EI, Burtness BA, Heitmiller RF, Salem R, Kleinberg L, Knisely JP, Yang SC, Talamini MA, Kaufman HS, Canto MI, Topazian M, Wu TT, Olukayode K, Forastiere AA.
    J Clin Oncol; 2000 Feb 01; 18(4):868-76. PubMed ID: 10673530
    [Abstract] [Full Text] [Related]

  • 31. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA, Hainsworth JD, Gray JR, Thomas M, Whitworth PL, Davis JL, Greco FA.
    Cancer J Sci Am; 1999 Feb 01; 5(2):84-91. PubMed ID: 10198730
    [Abstract] [Full Text] [Related]

  • 32. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 33. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
    Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA.
    N Engl J Med; 1998 Dec 31; 339(27):1979-84. PubMed ID: 9869669
    [Abstract] [Full Text] [Related]

  • 34. Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease.
    Stiles BM, Mirza F, Coppolino A, Port JL, Lee PC, Paul S, Altorki NK.
    Ann Thorac Surg; 2011 Aug 31; 92(2):491-6; discussion 496-8. PubMed ID: 21704291
    [Abstract] [Full Text] [Related]

  • 35. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M, Kornek GV, Schratter-Sehn AU, Zach M, Schoder M, Raderer M, Rosen H, Schiessel R, Scheithauer W.
    Cancer; 1996 Oct 15; 78(8):1646-50. PubMed ID: 8859175
    [Abstract] [Full Text] [Related]

  • 36. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H, Sueyoshi S, Tanaka T, Tanaka Y, Sasahara H, Shirouzu K, Suzuki G, Hayabuchi N, Inutsuka H.
    J Surg Oncol; 2005 Jun 15; 90(4):209-19. PubMed ID: 15906363
    [Abstract] [Full Text] [Related]

  • 37. [Neoadjuvant treatment in surgery of esophageal cancer].
    Launois B, Raoul JL, Leprise E, Meunier B.
    Bull Acad Natl Med; 2000 Jun 15; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
    [Abstract] [Full Text] [Related]

  • 38. Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer.
    Shimakawa T, Naritaka Y, Asaka S, Isohata N, Murayama M, Konno S, Yoshimatsu K, Shiozawa S, Katsube T, Ogawa K.
    Anticancer Res; 2008 Jun 15; 28(4C):2321-6. PubMed ID: 18751413
    [Abstract] [Full Text] [Related]

  • 39. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
    Imdahl A, Schöffel U, Ruf G, Hopf UT.
    Zentralbl Chir; 2004 Oct 15; 129(5):350-5. PubMed ID: 15486784
    [Abstract] [Full Text] [Related]

  • 40. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP, Jones M, Gonen M, Gotley DC, Thomas J, Thomson DB, Burmeister B, Smithers BM.
    Ann Surg Oncol; 2008 Oct 15; 15(10):2894-902. PubMed ID: 18663531
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 172.